Yuangbing Xu

Non-coplanar VMAT improves plan quality for locoregional radiotherapy of left-sided breast cancer with internal mammary nodes

J. Dai, Zhihui Hu, K. Men, 2020 .

Selection of prescription isodose line for brain metastases treated with volumetric modulated arc radiotherapy

J. Dai, P. Ma, Ying-jie Xu, 2019, Journal of applied clinical medical physics.

Non-coplanar Volumetric Modulated Arc Therapy for Locoregional Radiotherapy of Left-sided Breast Cancer Including Internal Mammary Nodes

J. Dai, Zhihui Hu, K. Men, 2021, Radiology and oncology.

Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?

Hongsheng Liu, D. Ma, Shanqing Li, 2023, Thoracic cancer.

Treatment plan prescreening for patient-specific quality assurance measurements using independent Monte Carlo dose calculations

J. Dai, Kecheng Zhang, K. Men, 2022, Frontiers in Oncology.

Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases

J. Dai, K. Men, Jian-ping Xiao, 2022, Radiation oncology.

18F-FDG PET/CT for the early prediction of the response rate and survival of patients with recurrent or metastatic breast cancer

Shaoli Song, Jianju Liu, Yi-jin Yang, 2018, Oncology letters.

Is it necessary to perform measurement‐based patient‐specific quality assurance for online adaptive radiotherapy with Elekta Unity MR‐Linac?

K. Men, W. Xia, Wenting Ren, 2023, Journal of applied clinical medical physics.